An engineered gut bacteria therapy could be an alternative to foecal microbiota transplants (FMT), researchers say. Results from a Phase Ib clinical study demonstrate comparable safety and efficacy between stool-based FMT and manufactured live biotherapeutic product (LBP). Scientists at the Icahn School of Medicine at Mount Sinai, New York developed the… Read More
Skin bacteria could hold the key to safe treatments for eczema, new research suggests. A study led by scientists at The University of Manchester and Tokyo University of Agriculture and Technology found that harmless microbes living on our skin release powerful molecules, shutting down inflammation triggered by Staphylococcus… Read More
News round-up for 16 – 20 March February by Bruno Quinney, Content Team at DDW. This week, a pioneering method is being used to make drugs for Parkinson’s disease. Elsewhere, advances have been made in both research and trials for common cancers. The top stories: Edinburgh team… Read More
A drug to treat Parkinson’s disease can be made from waste plastic bottles using a pioneering method, a study shows. The approach harnesses bacteria to transform post-consumer plastic into L-DOPA, a frontline medication for the neurological disorder. It is the first time a natural, biological… Read More
A study investigating a life-threatening and contagious gut infection has launched in the UK – with researchers recruiting the first patient in the world to test a new preventative therapy. Clostridioides difficile, commonly known as C. difficile or ‘C. diff’, is a bacterium that lives in the… Read More
Manufacturer Omega Bio-tek has presented a new workflow offering a high-throughput, automation-friendly platform at SLAS2026. The workflow, developed in collaboration with Dynamic Devices, integrates the M1272 Mag-Bind Endo-free Plasmid Midi Kit. It is designed to meet the growing demand for scalable, endotoxin-free plasmid purification, which the company says is suitable for sensitive downstream applications including transfection, viral… Read More
The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW’s Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, innovative therapies showed the way to more effective cancer treatments. Elsewhere, how can… Read More
News round-up for 2 – 6 February by Bruno Quinney, Content Team at DDW. This week in DDW, innovative therapies could pave the way to more effective cancer treatments. Elsewhere, how can brain function be improved in Alzheimer’s patients? The top stories: Immunotherapy before surgery… Read More
Sugar molecules found on bacterial cells could offer a target to killing drug-resistant bacteria, scientists suggest. Researchers have designed antibodies that recognise the sugar found only on bacterial cells, which could underpin a new generation of immunotherapies for multidrug resistant hospital-acquired infections. The findings, published in … Read More
Southwest Research Institute (SwRI) and Trinity University have announced plans to study Thermus thermophilus, a thermal bacterium with highly stable proteins. The plan is to advance scientific understanding of stability mechanisms that could pave the way for advanced treatments for diseases such as Alzheimer’s, amyotrophic lateral sclerosis… Read More
The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW’s Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, research into bacterial species and diseases broke new ground. Elsewhere, vaccines could… Read More
News round-up for 17 – 21 November by Bruno Quinney, Content Team at DDW. This week in DDW, research into bacterial species and diseases gets top billing. Elsewhere, vaccines could offer groundbreaking solutions to cervical and lung cancer. The top stories: Medication detrimental to gut microbiome,… Read More
The effect of common medication on the gut microbiome could have a detrimental impact on metabolism, the immune system and overall health, a new study reveals. According to a new paper published in Cell Press, researchers at Stanford University, US, found that medications reduce certain bacterial populations and change… Read More
Scientists believe a vaccine could be developed to tackle Haemophilus influenzae (H. influenzae) bacteria, which causes up to 200 million childhood infections each year. An international team including researchers at the Wellcome Sanger Institute, the University of Oslo, the University of Oxford and the Shoklo Malaria Research Unit at Mahidol University in Thailand, found… Read More
Researchers from the UK and Madagascar, in collaboration with Madagascar’s health services and national plague programme, have conducted the world’s first rigorous clinical trial of treatments for bubonic plague. The IMASOY trial provides the first robust evidence of the efficacy and safety of two common treatment regimens. … Read More
Understanding the precise mechanism behind bacterial cell division can help in the development of targeted ways to inhibit bacterial proliferation. To this end, researchers in Japan have explored the structure and molecular basis of the interaction between bacterial cell division-associated proteins FtsZ and ZapA. Cell… Read More
